How many studies have been conducted on Interleukin 1 Receptor Antagonist Protein?

BiohacksAI has indexed 191 PubMed studies on Interleukin 1 Receptor Antagonist Protein, including 2 randomized controlled trials (RCTs). 35% of studies involve human subjects.

What are the main research areas for Interleukin 1 Receptor Antagonist Protein?

The primary research domains for Interleukin 1 Receptor Antagonist Protein are 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology. This is based on analysis of 191 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Interleukin 1 Receptor Antagonist Protein

A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA.

191+ PubMed studies analyzed · 2 RCTs · Evidence Score: 49.6

Research Domains

Interleukin 1 Receptor Antagonist Protein has been studied across 18 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology, 🛡️ Immunity, 🔥 Metabolic. The primary research focus is 🔬 Inflammation with 74% of studies addressing this area.

Loading evidence profile...

This evidence profile for Interleukin 1 Receptor Antagonist Protein is generated deterministically from 191 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.